Sanofi-Synthelabo Pharmaceuticals Pages on BioPortfolio:

BioPortfolio - synthelabo pharmaceuticals
Sanofi-Synthelabo Pharmaceuticals Incorporated. View the current Sanofi- Synthelabo Pharmaceuticals Incorporated Page on BioPortfolio.com . ...
http://www.bioportfolio.com/search/synthelabo_pharmaceutical...

BioPortfolio - Sanofi-Aventis FR tel
BioPortfolio - Sanofi Synthelabo Pharmaceuticals BioPortfolio - Sanofi-Aventis FR tel BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life . ...
http://www.bioportfolio.com/search/Sanofi-Aventis__FR_tel.ht...

BioPortfolio - Somerset Pharmaceuticals 2007
BioPortfolio - Somerset Pharmaceuticals 2007 BioPortfolio - Sanofi-Synthelabo Pharmaceuticals Incorporated Warning Letters and Untitled Letters to . ...
http://www.bioportfolio.com/search/Somerset_Pharmaceuticals_...

BioPortfolio - Mayne Pharma (USA) Inc
Bioportfolio - Sanofi-Synthelabo Pharmaceuticals Incorporated KV Pharmaceutical Company, Lannett Company Inc., Mayne Pharma USA Inc., . ...
http://www.bioportfolio.com/search/Mayne_Pharma_(USA)_Inc_.h...

BioPortfolio - lorex pharmaceuticals
Sanofi-Synthélabo a pharmaceutical company with a global dimension ... of Sanofi ’s sales force and the acquisition of Lorex Pharmaceuticals in 2002. ...
http://www.bioportfolio.com/search/lorex_pharmaceuticals_.ht...

BioPortfolio - Sanofi Pharmaceuticals Incorporated
Sanofi Pharmaceuticals are the U.S. subsidiary of Sanofi-Synthelabo, the global healthcare company. With annual sales in excess of $5.6 billion and 30000 ...
http://www.bioportfolio.com/biocorporate/9147-Sanofi_Pharmac...

BioPortfolio - sanofi-synthelabo
Pharma Live: Aug 22 2008 2:46AM Matching: sanofi synthelabo. Head-to-Head Study Showed Prasugrel Statistically Superior to Clopidogrel in Reducing Recurrent ...
http://www.bioportfolio.com/biocorporate/9150-sanofi-synthel...

BioPortfolio.com - BioWeb DOPAMINE DOPAMINE HYDROCHLORIDE Search
BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science .... INJECTION >D> ARALEN HCL >D> + SANOFI SYNTHELABO EQ 40MG BASE/ML N06002 002 ...
http://www.bioportfolio.co.uk/DOPAMINE+DOPAMINE+HYDROCHLORID...

Aventis and Sanofi: Merger speculation continues
Pharmaceuticals: Survival of the 'Fittest' - Can Competitive Advantage be Sustained Without M&A in the ... PharmaVitae 2003: Sanofi-Synthelabo - $2600.00
...
http://www.bioportfolio.com/news/datamonitor_50.htm...

Results from other life science and pharmaceutical sites:

Sanofi Aventis
US Headquarters for an international pharmaceutical company: careers, internships, products and clinical trials.
http://www.sanofi-aventis.us/...

sanofi-aventis : Un des leaders mondiaux de l’industrie pharmaceutique
Présentation du groupe et de ses activités de recherche, dossiers santé, résultats financiers, communiqués et dossiers de presse.
http://www.sanofi-aventis.com/...

BioPortfolio - synthelabo pharmaceuticals
Bioportfolio - Sanofi-Synthelabo Pharmaceuticals Incorporated KV Pharmaceutical ... View the current Sanofi-Synthelabo Pharmaceuticals Incorporated Page on ...
http://www.bioportfolio.com/search/synthelabo_pharmaceutical...

BioSpace - Sanofi-Synthelabo News, Search Jobs, Events
19 Oct 2005 ... In the U.S., as in other major markets, the principle area of business of Sanofi -Synthelabo is ethical pharmaceuticals. ...
http://www.biospace.com/company_profile.aspx?CompanyID=3581...

Sanofi-Synthelabo Research & Development
Sanofi-Synthelabo. Research & Development. Marc CLUZEL. Vice President, Development. Scientific Affairs. Merrill Lynch Global Pharmaceutical Conference
...
http://www.sanofi-aventis.com/Images/20030924_Merrill_Lynch_...

Valeant Pharmaceuticals International | News Releases | News Article
NEW YORK, November 11, 1999 - ICN Pharmaceuticals, Inc. (NYSE: ICN) today announced that an agreement has been reached with Sanofi-Synthelabo and Almirall
...
http://www.valeant.com/mediaCenter/newsArticle/newsArticle.j...

Home Marketing Services News Reports Company Profiles InDepth Drug Discovery Careers Conferences Videos Search Contact
	Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner. See User Agreement Send comments and feedback to: Peter Barfoot Managing Director, BioPortfolio Ltd. UK Tel: (+44) 1300 321501 USA Voicemail and Fax: (+1) 415 680 2472	All rights reserved. All other trademarks recognized. BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10 Copyright 1997-2008 - BioPortfolio Limited.